Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
Novartis Pharmaceuticals Corporation v. MSN Pharmaceuticals Inc., et al
Case Number:
1:22-cv-01395
Court:
Nature of Suit:
Patent - Abbreviated New Drug Application(ANDA)
Judge:
Firms
Companies
Sectors & Industries:
-
September 29, 2023
Generic Cos. Must Face IP Claims Over Novartis Blockbuster
A Delaware federal judge on Friday cleared Novartis Pharmaceuticals Corp. to proceed with infringement litigation against a pair of companies aiming to sell generic versions of its blockbuster cardiovascular drug Entresto.
-
October 25, 2022
Novartis Sues Viatris, Others In New IP Fight Over Heart Drug
Amid Novartis' ongoing multidistrict patent litigation against generic-drug makers over the heart medication Entresto, the Swiss pharmaceutical giant has now targeted Viatris and others in a new Delaware federal court infringement suit over another Entresto patent.